Hong Kong life insurance king who sponsors Williams F1 “Consider expanding investment in F1″[F1-Gate.com]

Hong Kong billionaire and life insurance tycoon Calvin Low, the investor suspected behind Dorilton Capital’s investment in Williams Racing, says he may increase his F1 investment. Told.

Dorilton Capital acquired the Williams F1 team from the team’s founding family in 2020.

Speculation at the time pointed to Calvin Law, chief executive of life insurance broker Lee International, as the man behind the investment in the US private equity firm.

Calvin Law has neither denied nor confirmed the speculation, confirming that he has “some connections” with Williams through Dorilton Capital, but did not provide details about his level of investment.

However, Calvin Law said F1’s recent impressive growth has caught the attention of investors in Asia, adding that investment opportunities in the sport are being considered.

“A lot of people, myself included, are still looking at other teams and other opportunities because…there are consistently good teams, but they haven’t been able to produce the right car. ‘” Calvin Law told Archyde.com.

“There’s a lot of liquidity in Asia right now, it’s amazing. The next news we hear is… Asian consortia may be investing in other teams.”

Calvin Low declined to disclose any potential F1 investment opportunities he or other investors have identified.

Sauber Motorsport is reportedly considering a sale to Audi, but Volkswagen affiliate Audi has not officially confirmed its interest in buying the F1 team from Sauber. do not have.

Additionally, the Haas F1 team, which is seen as a potential takeover target, has reportedly missed many opportunities to discuss acquisition plans with Michael Andretti.

“He doesn’t want to sell it to me right now,” Andretti said last winter, referring to team owner Gene Haas of Haas F1 Team.

“If he wants to sell it, he can call me anytime. It’s very easy for everyone.”

Calvin Law

Add this entry to Hatena Bookmark

Category: F1 / Williams

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.